Logo

Latest Press Releases

July 11, 2025
Neurona Announces Publication in Neuron Reporting Durable Preclinical Engraftment of Human Interneuron Cell Therapy 

June 18, 2025
Neurona Doses First Patient in Phase 1/2 Trial of NRTX-1001 Cell Therapy in Adults with Drug-Resistant, Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

April 8, 2025
Neurona Therapeutics Presents Positive Clinical Data Update from NRTX-1001 Cell Therapy Trial in Drug-resistant Epilepsy at American Academy of Neurology Annual Meeting

More Press Releases

photo of neuron

In the news

Click to play video of Interview with patient caregiver

Interview with patient caregiver at the XVII Conference on Epilepsy Therapies & Diagnostics Development (ETDD)
(with permission from ETDD, patient and caregiver)

August 25, 2025
Regenerative medicine offers new hope for lasting seizure relief for drug-resistant epilepsy

June 19, 2025
UChicago Medicine doctors provide pioneering stem cell surgery to patient with drug-resistant epilepsy

June 17, 2025
UAMS performs state's first cell therapy epilepsy Surgery

More News Articles

Events

There are no upcoming events at this time.

More Events

  • About
    • Mission / Vision
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Investors
  • Technology
    • Approach
    • Manufacturing
    • Publications
    • Scientific Presentations
  • Pipeline
    • Programs
  • Clinical Trials
    • NTE001 Unilateral MTLE Trial
    • CT.gov: NTE001
    • NTE002 Bilateral MTLE Trial
    • CT.gov: NTE002
    • Expanded Access Program
  • News
    • Press Releases
    • In the News
    • Events
  • Careers
    • Culture
    • Values
    • Benefits
    • Visiting Scientists & Internship programs
    • Job Opportunities
  • Contact
  • Home
  • About
    • Mission / Vision
    • Leadership
    • Board of Directors
    • Scientific Advisors
    • Investors
  • Technology
    • Approach
    • Manufacturing
    • Publications
    • Scientific Presentations
  • Pipeline
    • Programs
  • Clinical Trials
    • NTE001 Unilateral MTLE Trial
    • CT.gov: NTE001
    • NTE002 Bilateral MTLE Trial
    • CT.gov: NTE002
    • Expanded Access Program
  • News
    • Press Releases
    • In the News
    • Events
  • Careers
    • Culture
    • Values
    • Benefits
    • Visiting Scientists & Internship programs
    • Job Opportunities
  • Contact
Logo
Neurona Therapeutics
170 Harbor Way
South San Francisco, CA 94080
info@neuronatx.com
LinkedIn
© 2025 Neurona Therapeutics All rights reserved
  • Terms of Use
  • Privacy Policy
Website Design : Hane Chow, Inc.